PTK2 and neoplasm: Patient survival in both small-cell lung and non-small-cell lung cancers did not correlate with increased levels of nuclear pY397 FAK24, suggesting that nuclear pY397 FAK may play different roles in the progression and aggressiveness of different tumor types.